Back

PRIME Education, Inc. (PRIME®)

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Recognition, Psychology

Escalate, Achieve, Optimize: Advancing LDL-C Management in Primary Care

Despite widespread statin use, many patients with atherosclerotic cardiovascular disease (ASCVD) fail to achieve recommended LDL-C targets, leaving them vulnerable to preventable cardiovascular events. In primary care, barriers such as uncertainty around treatment escalation, inconsistent LDL-C monitoring, and limited familiarity with non-statin therapies can delay optimal care. Tune in as expert faculty in lipid management review current evidence and the latest updates in guideline-directed LDL-C management, with a focus on intensifying therapy when statins alone are not enough. Through a real-world patient case, faculty demonstrate how to apply practical tools from the ASCVD Prevention Optimization Guide to support timely treatment escalation, individualized therapy selection, and appropriate referral to specialists for complex cases. Designed to support immediate practice change, offers actionable strategies to integrate guideline-recommended LDL-C monitoring, optimize use of non-statin therapies, and streamline treatment decision-making in busy primary care settings.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case study / clinical scenario
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Jul 17, 2026
  • Last day to claim credit
    Jul 17, 2027 9 months left